Praxis Precision Medicines Inc
PRAX55.650USD
-3.570-6.03%
收盘 07/28, 16:00（美东）报价延迟15分钟
1.13B总市值
亏损市盈率 TTM
关于 Praxis Precision Medicines Inc 公司
Praxis Precision Medicines, Inc. 是一家临床阶段的生物制药公司。该公司专注于将对遗传性癫痫的洞察转化为以神经元兴奋-抑制失衡为特征的中枢神经系统疾病的治疗方法的开发。该公司利用对大脑中共同的生物靶点和回路的理解，通过两个平台将遗传学见解应用于神经系统疾病疗法的发现和开发。其平台包括 Cerebrum，这是一个小分子平台，利用对神经元兴奋性和神经元网络的深入了解，并应用一系列计算和实验工具来开发口服精准疗法；Solidus 是一个反义寡核苷酸平台，是一种基于专有计算方法的高效、有针对性的精准药物发现和开发引擎。其候选产品包括 ulixacaltamide、PRAX-562、PRAX-628 和 elsunersen。
公司简介
公司代码PRAX
公司名称Praxis Precision Medicines Inc
上市日期Oct 16, 2020
成立日期2015
CEOMr. Marcio Souza
员工数量116
证券类型Ordinary Share
年结日Oct 16
公司地址99 High Street, 30th Floor
城市BOSTON
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编02110
电话16173008460
网址https://praxismedicines.com/
公司代码PRAX
上市日期Oct 16, 2020
成立日期2015
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Alex Nemiroff, J.D.
Mr. Alex Nemiroff, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
3.94K
-80.31%
Ms. Jill Desimone
Ms. Jill Desimone
Independent Director
Independent Director
966.00
--
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
188.00
--
Mr. William Young
Mr. William Young
Independent Director
Independent Director
--
--
Mr. Marcio Souza
Mr. Marcio Souza
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Dean Mitchell
Mr. Dean Mitchell
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Timothy E. (Tim) Kelly
Mr. Timothy E. (Tim) Kelly
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Jeffrey A. (Jeff) Chodakewitz, M.D.
Dr. Jeffrey A. (Jeff) Chodakewitz, M.D.
Independent Director
Independent Director
--
--
Dr. Merit Cudkowicz, M.D.
Dr. Merit Cudkowicz, M.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Alex Nemiroff, J.D.
Mr. Alex Nemiroff, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
3.94K
-80.31%
Ms. Jill Desimone
Ms. Jill Desimone
Independent Director
Independent Director
966.00
--
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
188.00
--
Mr. William Young
Mr. William Young
Independent Director
Independent Director
--
--
Mr. Marcio Souza
Mr. Marcio Souza
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Dean Mitchell
Mr. Dean Mitchell
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 6月11日 周三
更新时间: 6月11日 周三
持股股东
股东类型
持股股东
持股股东
占比
Janus Henderson Investors
11.29%
Cormorant Asset Management, LP
8.57%
Adage Capital Management, L.P.
8.56%
Perceptive Advisors LLC
6.69%
BlackRock Institutional Trust Company, N.A.
6.29%
Other
58.61%
持股股东
持股股东
占比
Janus Henderson Investors
11.29%
Cormorant Asset Management, LP
8.57%
Adage Capital Management, L.P.
8.56%
Perceptive Advisors LLC
6.69%
BlackRock Institutional Trust Company, N.A.
6.29%
Other
58.61%
股东类型
持股股东
占比
Hedge Fund
42.46%
Investment Advisor
31.95%
Investment Advisor/Hedge Fund
27.63%
Research Firm
8.89%
Private Equity
6.69%
Venture Capital
6.52%
Sovereign Wealth Fund
0.58%
Bank and Trust
0.22%
Pension Fund
0.22%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
340
24.94M
122.42%
-159.68K
2025Q1
354
23.88M
117.36%
-1.32M
2024Q4
340
21.98M
109.07%
-1.43M
2024Q3
328
19.19M
107.78%
-2.59M
2024Q2
309
18.51M
104.24%
+1.04M
2024Q1
301
15.97M
96.49%
+5.95M
2023Q4
275
8.07M
91.87%
-1.62M
2023Q3
277
7.85M
94.33%
-1.72M
2023Q2
277
8.02M
96.64%
+3.13M
2023Q1
273
3.78M
97.85%
-268.38K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Janus Henderson Investors
2.30M
11.29%
+793.79K
+52.69%
May 30, 2025
Cormorant Asset Management, LP
1.75M
8.57%
+51.78K
+3.06%
Mar 31, 2025
Adage Capital Management, L.P.
1.74M
8.56%
+1.14M
+188.05%
Mar 31, 2025
Perceptive Advisors LLC
980.89K
4.82%
-348.84K
-26.23%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.28M
6.29%
-59.65K
-4.45%
Mar 31, 2025
Soleus Capital Management, L.P.
1.14M
5.6%
+896.20K
+367.99%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.10M
5.41%
+21.46K
+1.99%
Mar 31, 2025
The Vanguard Group, Inc.
1.08M
5.32%
+23.38K
+2.21%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.07M
5.25%
-113.46K
-9.59%
Mar 31, 2025
VR Adviser, LLC
989.99K
4.86%
--
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
iShares Neuroscience and Healthcare ETF
1.72%
Global X Genomics & Biotechnology ETF
1.01%
Virtus LifeSci Biotech Clinical Trials ETF
0.87%
ALPS Medical Breakthroughs ETF
0.69%
Tema Neuroscience and Mental Health ETF
0.4%
SPDR S&P Biotech ETF
0.27%
Direxion Daily S&P Biotech Bull 3X Shares
0.16%
iShares Micro-Cap ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.1%
Invesco Nasdaq Biotechnology ETF
0.09%
查看更多
iShares Neuroscience and Healthcare ETF
占比1.72%
Global X Genomics & Biotechnology ETF
占比1.01%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.87%
ALPS Medical Breakthroughs ETF
占比0.69%
Tema Neuroscience and Mental Health ETF
占比0.4%
SPDR S&P Biotech ETF
占比0.27%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.16%
iShares Micro-Cap ETF
占比0.15%
ProShares Ultra Nasdaq Biotechnology
占比0.1%
Invesco Nasdaq Biotechnology ETF
占比0.09%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Nov 22, 2023
Merger
15<1
Nov 22, 2023
Merger
15<1
Nov 22, 2023
Merger
15<1
Nov 22, 2023
Merger
15<1
公告日期
类型
比率
Nov 22, 2023
Merger
15<1
Nov 22, 2023
Merger
15<1
Nov 22, 2023
Merger
15<1
Nov 22, 2023
Merger
15<1
